Rising Prevalence Of Neurological Disorders Fuels Growth In The Peripheral Nerve Stimulators Market: A Key Factor Shaping the Future of the Peripheral Nerve Stimulators Market in 2025

What Are the Projections for the Size and Growth Rate of the Peripheral Nerve Stimulators Market?
The market size of peripheral nerve stimulators has seen significant expansion in the past few years. The market projection shows an increase from $0.70 billion in 2024 to $0.77 billion in 2025, with a compound annual growth rate (CAGR) of 9.35%. This growth during the historic period is due to an increased demand for non-drug pain management solutions, a heightened awareness of alternative pain relief therapies, greater usage of minimally invasive procedures, a rise in the aging population, and an increase in the number of clinics devoted to pain management.

The market for peripheral nerve stimulators is anticipated to experience robust growth in the upcoming years, expanding to $1.08 billion by 2029 with a compound annual growth rate (CAGR) of 8.98%. The growth expected in the forecast timeframe can be linked to favorable government policies and initiatives, an increasing inclination towards outpatient and home-based treatments, a burgeoning number of pain management clinics, a rising demand for personalized PNS devices, and an expanding healthcare infrastructure. Key trends within the forecast period encompass the creation of wireless peripheral nerve stimulators, the incorporation of mobile apps for remote monitoring of PNS devices, the debut of wearable, non-invasive PNS devices, and the launch of sophisticated PNS systems equipped with AI-based pain management features.

What Are the Main Catalysts for Growth in the Peripheral Nerve Stimulators Market?
The surge in occurrences of neurological conditions is projected to drive the peripheral nerve stimulators market's expansion. These disorders, which disturb the brain, spinal cord, or peripheral nerves leading to changes in function, structure, or biochemistry, are widespread. The rise in these disorders can be attributed to aging demographics, genetic predispositions, effects of the environment, lifestyle decisions, and heightened diagnosis and awareness. Peripheral nerve stimulators are critical in reducing these neurological conditions by providing targeted chronic pain relief, improving motor functions, and encouraging nerve renewal in impacted areas. As per the US-based Alzheimer's Association, a volunteer health organization, in March 2023, about 6.7 million American seniors aged 65 and above were living with Alzheimer's dementia. This figure is expected to balloon to 13.8 million by 2060. Thus, the escalating incidence of neurological disorders is spurring the growth of the peripheral nerve stimulators market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20923&type=smp

Which Businesses Are at the Forefront of Peripheral Nerve Stimulators Market Development?
Major companies operating in the peripheral nerve stimulators market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Globus Medical Inc., Livanova plc, Nevro Corp., Axonics Modulation Technologies, Saluda Medical Pty Ltd., Stimwave Technologies Incorporated, Nalu Medical Inc., Bioness Inc., SPR Therapeutics Inc., Neuspera Medical Inc., B. Braun Melsungen AG, NeuroMetrix Inc., BioElectronics Corporation, Soterix Medical Inc., Xavant Technology Pty Ltd., Neurostimulation Technologies, STIM Systems

How Is the Peripheral Nerve Stimulators Market Evolving?
Leading players in the peripheral nerve stimulators market are honing their focus on the creation of innovative products such as ultra-miniaturized systems. Their goal is to boost patient comfort, improve results of treatments, and broaden use in different therapeutic locations. Ultra-miniaturized systems embody compact and small devices built for advanced operations, often making use of state-of-the-art technology to amplify performance, adaptability, and integration in various applications. To illustrate, NeuSpera Medical Inc., a US firm known for manufacturing implantable medical devices, made an announcement in April 2023 about obtaining U.S. Food and Drug Administration (FDA) approval for their next-gen Neuspera ultra-miniaturized system meant for chronic peripheral nerve pain management. This specific device is designed in a unique manner to provide targeted electro impulses to peripheral nerves, bypassing the need for conventional leads, thus achieving minimal invasiveness and curbing the possibility of complications related to devices that use leads. Its smaller size facilitates comfortable implantation with lesser tissue damage, leading to expedited recovery periods. By directly triggering the affected nerve pathways, the micro-implant offers a possibility for long-term relief from pain, bringing forth a sophisticated alternative for individuals contending with chronic peripheral nerve pain.

How Is the Peripheral Nerve Stimulators Market Segmented?
The peripheral nerve stimulators market covered in this report is segmented -

1) By Product: Transcutaneous, Percutaneous, Implantable
2) By Device: Stimulators, CPNB Catheters, Pain Pumps, Other Devices
3) By Mode of Purchase: Disposable Devices, Rechargeable Devices
4) By Application: Hospitals, Physiotherapy Centers, Ambulatory Surgical Centers, Clinics, Other Applications

Subsegments:
1) By Transcutaneous: TENS (Transcutaneous Electrical Nerve Stimulation) Units, Surface Electrodes
2) By Percutaneous: Single-Needle Percutaneous Stimulators, Multi-Needle Percutaneous Stimulators, Radiofrequency Percutaneous Stimulators
3) By Implantable: Spinal Cord Stimulators (SCS), Peripheral Nerve Stimulation (PNS) Devices, Neurostimulator Implants

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/peripheral-nerve-stimulators-global-market-report

Where Is the Peripheral Nerve Stimulators Market Growth Most Prominent?
North America was the largest region in the peripheral nerve stimulators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral nerve stimulators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Peripheral Nerve Stimulators Global Market Report?

- Market Size Analysis: Analyze the peripheral nerve stimulators Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the peripheral nerve stimulators Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall peripheral nerve stimulators market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the peripheral nerve stimulators market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20923

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.